National Institute of Mental Health; Notice of Meeting, 16217-16218 [2017-06407]
Download as PDF
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 62 / Monday, April 3, 2017 / Notices
preparedness and response. Pursuant to
the Federal Advisory Committee Act
(FACA) of 1972 (5 U.S.C., Appendix, as
amended), and section 2811A of the
Public Health Service (PHS) Act (42
U.S.C. 300hh–10a), as added by section
103 of the Pandemic and All Hazards
Preparedness Reauthorization Act of
2013 (Pub. L. 113–5), the HHS
Secretary, in consultation with the
Secretary of the U.S. Department of
Homeland Security, established the
NACCD. The purpose of the NACCD is
to provide advice and consultation to
the HHS Secretary with respect to the
medical and public health needs of
children in relation to disasters.
Background: The NPRSB public
meeting on April 12, 2017, will be
dedicated to the swearing-in of one new
voting member and the re-appointment
of five existing members. The NPRSB
and NACCD will hold a joint public
meeting and ASPR Day on April 13,
2017, with presentations on ASPR
priorities, the National Health Security
Strategy, and stakeholder updates.
Subsequent agenda topics will be added
as priorities dictate. Any additional
agenda topics will be available on the
April 12 and 13, 2017 meeting Web
pages of the NPRSB and NACCD, which
are available at https://www.phe.gov/
nprsb and https://www.phe.gov/naccd.
Availability of Materials: The joint
meeting agenda and materials are posted
prior to the meeting on April 12 and 13,
2017 meeting Web pages at https://
www.phe.gov/nprsb and https://
www.phe.gov/naccd.
Procedures for Providing Public Input:
Members of the public attend in-person
or by teleconference via a toll-free callin phone number, which is available on
the NPRSB or NACCD Web sites at
https://www.phe.gov/nprsb and https://
www.phe.gov/naccd. All members of the
public are encouraged to provide
written comment to the NPRSB and
NACCD. Submit all written comments
prior to April 12, 2017, to their Web
sites, under the ‘‘Contact Us’’ link, at
https://www.phe.gov/nprsb and https://
www.phe.gov/naccd with ‘‘NACCD
Public Comment’’ or ‘‘NPRSB Public
Comment’’ as the subject line. Public
comments received by close of business
one week prior to the teleconference are
distributed to the NACCD or NPRSB.
Dated: March 13, 2017.
George W. Korch, Jr.,
Acting Assistant Secretary for Preparedness
and Response.
[FR Doc. 2017–06409 Filed 3–31–17; 8:45 am]
BILLING CODE 4150–28–P
VerDate Sep<11>2014
18:32 Mar 31, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; AIDSRRC Independent SEP.
Date: April 25, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Peter R. Jackson, Ph.D.,
Chief, AIDS Research Review Branch,
Scientific Review Program, Division of
Extramural Activities, Room #3G20, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5049, pjackson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: March 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06403 Filed 3–31–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health (NIH)
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Autism
Coordinating Committee (IACC or
Committee) meeting.
The purpose of the IACC meeting is
to discuss business, agency updates, and
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
16217
issues related to autism spectrum
disorder (ASD) research and services
activities. The Committee will discuss
the 2017 update of the IACC Strategic
Plan. The meeting will be open to the
public and will be accessible by webcast
and conference call.
Name of Committee: Interagency
Autism Coordinating Committee (IACC).
Type of meeting: Open Meeting.
Date: April 26, 2017.
Time: 9:00 a.m. to 5:00 p.m.* Eastern
Time * Approximate end time.
Agenda: To discuss business, updates,
and issues related to ASD research and
services activities. The Committee will
discuss updates of the IACC Strategic
Plan.
Place: National Institutes of Health,
31 Center St, Building 31, C Wing, 6th
Floor, Conference Room 6, Bethesda,
MD 20892.
Webcast Live: https://
videocast.nih.gov.
Conference Call Access: Dial: 800–
857–9708; Access code: 4617338.
Cost: The meeting is free and open to
the public.
Registration: A registration web link
will be posted on the IACC Web site
(www.iacc.hhs.gov) prior to the meeting.
Pre-registration is recommended to
expedite check-in. Seating in the
meeting room is limited to room
capacity and on a first come, first served
basis. Onsite registration will also be
available.
Deadlines:
Notification of intent to present oral
comments: Friday, April 14, 2017 by
5:00 p.m. ET.
Submission of written/electronic
statement for oral comments: Tuesday,
April 18, 2017 by 5:00 p.m. ET.
Submission of written comments:
Tuesday, April 18, 2017 by 5:00 p.m.
ET.
For IACC Public Comment guidelines
please see: https://iacc.hhs.gov/
meetings/public-comments/guidelines/.
Access: Medical Center Metro Station
(Red Line).
Contact Person: Ms. Angelice
Mitrakas, Office of Autism Research
Coordination, National Institute of
Mental Health, NIH, 6001 Executive
Boulevard, Room 6182A, Bethesda, MD
20892–9669, Phone: 301–435–9269,
Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments
Any member of the public interested
in presenting oral comments to the
Committee must notify the Contact
Person listed on this notice by 5:00 p.m.
ET on Friday, April 14, 2017, with their
request to present oral comments at the
meeting, and a written/electronic copy
E:\FR\FM\03APN1.SGM
03APN1
mstockstill on DSK3G9T082PROD with NOTICES
16218
Federal Register / Vol. 82, No. 62 / Monday, April 3, 2017 / Notices
of the oral presentation/statement must
be submitted by 5:00 p.m. ET on
Tuesday, April 18, 2017. A limited
number of slots for oral comment are
available, and in order to ensure that as
many different individuals are able to
present throughout the year as possible,
any given individual only will be
permitted to present oral comments
once per calendar year (2017). Only one
representative of an organization will be
allowed to present oral comments in
any given meeting; other representatives
of the same group may provide written
comments. If the oral comment session
is full, individuals who could not be
accommodated are welcome to provide
written comments instead. Comments to
be read or presented in the meeting
must not exceed 250 words or 3
minutes, but a longer version may be
submitted in writing for the record.
Commenters going beyond the 250 word
or 3 minute time limit in the meeting
may be asked to conclude immediately
in order to allow other comments and
presentations to proceed on schedule.
Any interested person may submit
written public comments to the IACC
prior to the meeting by emailing the
comments to IACCPublicInquiries@
mail.nih.gov or by submitting comments
at the web link: https://iacc.hhs.gov/
meetings/public-comments/submit/
index.jsp by 5:00 p.m. ET on Tuesday,
April 18, 2017. The comments should
include the name, address, telephone
number, and when applicable, the
business or professional affiliation of
the interested person. NIMH anticipates
written public comments received by
5:00 p.m. ET on Tuesday, April 18, 2017
will be presented to the Committee prior
to the meeting for the Committee’s
consideration. Any written comments
received after the 5:00 p.m. ET, April
14, 2017 deadline through April 18,
2017 will be provided to the Committee
either before or after the meeting,
depending on the volume of comments
received and the time required to
process them in accordance with
privacy regulations and other applicable
Federal policies. All written public
comments and oral public comment
statements received by the deadlines for
both oral and written public comments
will be provided to the IACC for their
consideration and will become part of
the public record. Attachments of
copyrighted publications are not
permitted, but web links or citations for
any copyrighted works cited may be
provided.
In the 2009 IACC Strategic Plan, the
IACC listed the ‘‘Spirit of Collaboration’’
as one of its core values, stating that,
‘‘We will treat others with respect, listen
to diverse views with open minds,
VerDate Sep<11>2014
18:32 Mar 31, 2017
Jkt 241001
discuss submitted public comments,
and foster discussions where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
(OARC) ask that members of the public
who provide public comments or
participate in meetings of the IACC also
seek to treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
Remote Access
The meeting will be open to the
public through a conference call phone
number and webcast live on the
Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an email to IACCPublicInquiries@
mail.nih.gov.
Individuals wishing to participate in
person or by using these electronic
services and who need special
assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a
request to the Contact Person listed on
this notice at least five days prior to the
meeting.
Security
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs and
hotel and airport shuttles, will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. Also as a part of
security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
on a first come, first served basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
Information about the IACC is
available on the Web site: https://
www.iacc.hhs.gov.
Dated: March 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06407 Filed 3–31–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Neuroimmunology and Brain Tumor SEP.
Date: April 14, 2017.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV and Related Research.
Date: April 19, 2017.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–451–2796, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical Oncology.
Date: April 25, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Nicholas J. Donato, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040,
Bethesda, MD 20817, 301–827–4810,
nick.donato@nih.gov.
E:\FR\FM\03APN1.SGM
03APN1
Agencies
[Federal Register Volume 82, Number 62 (Monday, April 3, 2017)]
[Notices]
[Pages 16217-16218]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health (NIH)
National Institute of Mental Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of an Interagency
Autism Coordinating Committee (IACC or Committee) meeting.
The purpose of the IACC meeting is to discuss business, agency
updates, and issues related to autism spectrum disorder (ASD) research
and services activities. The Committee will discuss the 2017 update of
the IACC Strategic Plan. The meeting will be open to the public and
will be accessible by webcast and conference call.
Name of Committee: Interagency Autism Coordinating Committee
(IACC).
Type of meeting: Open Meeting.
Date: April 26, 2017.
Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end time.
Agenda: To discuss business, updates, and issues related to ASD
research and services activities. The Committee will discuss updates of
the IACC Strategic Plan.
Place: National Institutes of Health, 31 Center St, Building 31, C
Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Webcast Live: https://videocast.nih.gov.
Conference Call Access: Dial: 800-857-9708; Access code: 4617338.
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
Web site (www.iacc.hhs.gov) prior to the meeting. Pre-registration is
recommended to expedite check-in. Seating in the meeting room is
limited to room capacity and on a first come, first served basis.
Onsite registration will also be available.
Deadlines:
Notification of intent to present oral comments: Friday, April 14,
2017 by 5:00 p.m. ET.
Submission of written/electronic statement for oral comments:
Tuesday, April 18, 2017 by 5:00 p.m. ET.
Submission of written comments: Tuesday, April 18, 2017 by 5:00
p.m. ET.
For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
Access: Medical Center Metro Station (Red Line).
Contact Person: Ms. Angelice Mitrakas, Office of Autism Research
Coordination, National Institute of Mental Health, NIH, 6001 Executive
Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone: 301-435-9269,
Email: IACCPublicInquiries@mail.nih.gov.
Public Comments
Any member of the public interested in presenting oral comments to
the Committee must notify the Contact Person listed on this notice by
5:00 p.m. ET on Friday, April 14, 2017, with their request to present
oral comments at the meeting, and a written/electronic copy
[[Page 16218]]
of the oral presentation/statement must be submitted by 5:00 p.m. ET on
Tuesday, April 18, 2017. A limited number of slots for oral comment are
available, and in order to ensure that as many different individuals
are able to present throughout the year as possible, any given
individual only will be permitted to present oral comments once per
calendar year (2017). Only one representative of an organization will
be allowed to present oral comments in any given meeting; other
representatives of the same group may provide written comments. If the
oral comment session is full, individuals who could not be accommodated
are welcome to provide written comments instead. Comments to be read or
presented in the meeting must not exceed 250 words or 3 minutes, but a
longer version may be submitted in writing for the record. Commenters
going beyond the 250 word or 3 minute time limit in the meeting may be
asked to conclude immediately in order to allow other comments and
presentations to proceed on schedule.
Any interested person may submit written public comments to the
IACC prior to the meeting by emailing the comments to
IACCPublicInquiries@mail.nih.gov or by submitting comments at the web
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by
5:00 p.m. ET on Tuesday, April 18, 2017. The comments should include
the name, address, telephone number, and when applicable, the business
or professional affiliation of the interested person. NIMH anticipates
written public comments received by 5:00 p.m. ET on Tuesday, April 18,
2017 will be presented to the Committee prior to the meeting for the
Committee's consideration. Any written comments received after the 5:00
p.m. ET, April 14, 2017 deadline through April 18, 2017 will be
provided to the Committee either before or after the meeting, depending
on the volume of comments received and the time required to process
them in accordance with privacy regulations and other applicable
Federal policies. All written public comments and oral public comment
statements received by the deadlines for both oral and written public
comments will be provided to the IACC for their consideration and will
become part of the public record. Attachments of copyrighted
publications are not permitted, but web links or citations for any
copyrighted works cited may be provided.
In the 2009 IACC Strategic Plan, the IACC listed the ``Spirit of
Collaboration'' as one of its core values, stating that, ``We will
treat others with respect, listen to diverse views with open minds,
discuss submitted public comments, and foster discussions where
participants can comfortably offer opposing opinions.'' In keeping with
this core value, the IACC and the NIMH Office of Autism Research
Coordination (OARC) ask that members of the public who provide public
comments or participate in meetings of the IACC also seek to treat
others with respect and consideration in their communications and
actions, even when discussing issues of genuine concern or
disagreement.
Remote Access
The meeting will be open to the public through a conference call
phone number and webcast live on the Internet. Members of the public
who participate using the conference call phone number will be able to
listen to the meeting but will not be heard. If you experience any
technical problems with the webcast or conference call, please send an
email to IACCPublicInquiries@mail.nih.gov.
Individuals wishing to participate in person or by using these
electronic services and who need special assistance, such as captioning
of the conference call or other reasonable accommodations, should
submit a request to the Contact Person listed on this notice at least
five days prior to the meeting.
Security
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs and hotel and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit. Also as
a part of security procedures, attendees should be prepared to present
a photo ID at the meeting registration desk during the check-in
process. Pre-registration is recommended. Seating will be limited to
the room capacity and seats will be on a first come, first served
basis, with expedited check-in for those who are pre-registered.
Meeting schedule subject to change.
Information about the IACC is available on the Web site: https://www.iacc.hhs.gov.
Dated: March 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06407 Filed 3-31-17; 8:45 am]
BILLING CODE 4140-01-P